Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



LYONS GARY A Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 LYONS GARY A (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 30,000 options to buy @ $1.32, valued at $39.6k
05/19/2023 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 4,290 options to buy @ $95.27, valued at $408.7k
Granted 2,100 restricted stock units @ $0
05/19/2023 4 LYONS GARY A (Director) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
Granted 13,500 options to buy @ $17.11, valued at $231k
05/02/2023 4 LYONS GARY A (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 5,000 shares @ $110.5422, valued at $552.7k
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2022 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 15,000 shares @ $92.7595, valued at $1.4M
Exercised 15,000 options to buy @ $6.66, valued at $99.9k
02/02/2022 4 LYONS GARY A (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $3.97, valued at $79.4k
10/12/2021 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 5,000 shares @ $105.0587, valued at $525.3k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 1,600 shares @ $120.0291, valued at $192k
Sold 400 shares @ $120, valued at $48k
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/17/2020 4 LYONS GARY A (Director) has filed a Form 4 on Brickell Biotech, Inc.
Txns: Granted 11,934 shares @ $0.81, valued at $9.7k
Granted 60,000 options to buy @ $0.8, valued at $48k
09/15/2020 4 LYONS GARY A (Director) has filed a Form 4 on Novus Therapeutics, Inc.
Txns: Granted 1,167 options to buy @ $500, valued at $583.6k
09/02/2020 4 LYONS GARY A (Director) has filed a Form 4 on Brickell Biotech, Inc.
Txns: Paid exercise price by delivering 346 shares @ $0.94, valued at $325.2
Paid exercise price by delivering 8,631 shares @ $0.94, valued at $8.1k
Exercised 692 restricted stock units @ $0
08/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 LYONS GARY A (Director) has filed a Form 4 on Brickell Biotech, Inc.
Txns: Paid exercise price by delivering 1,746 shares @ $1.16, valued at $2k
Paid exercise price by delivering 346 shares @ $2.93, valued at $1k
Paid exercise price by delivering 346 shares @ $1.19, valued at $411.7
Paid exercise price by delivering 346 shares @ $1.2, valued at $415.2
Paid exercise price by delivering 346 shares @ $1.16, valued at $401.4
Granted 17,261 shares @ $0
Exercised 3,491 restricted stock units @ $0
Exercised 692 restricted stock units @ $0
Exercised 691 restricted stock units @ $0
Exercised 692 restricted stock units @ $0
Exercised 692 restricted stock units @ $0
05/21/2020 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 6,018 options to buy @ $119.93, valued at $721.7k
05/19/2020 4 LYONS GARY A (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 3,000 shares @ $0
Granted 9,000 options to buy @ $15.43, valued at $138.9k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/05/2019 4 LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 5,000 shares @ $100.2207, valued at $501.1k
07/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy